Vincent Anzalone | VP, IR |
Christopher Anzalone | CEO, President & Director |
James Hamilton | SVP, Discovery & Translational Medicine |
Kenneth Myszkowski | CFO |
James Hassard | Chief Commercial Officer |
Salveen Richter | Goldman Sachs Group |
Maurice Raycroft | Jefferies |
Shawn Egan | Citigroup |
Luca Issi | RBC Capital Markets |
Esther Rajavelu | UBS Investment Bank |
Edward Tenthoff | Piper Sandler & Co. |
Li Watsek | Cantor Fitzgerald |
Patrick Trucchio | H.C. Wainwright & Co. |
Mayank Mamtani | B. Riley Securities, Inc. |
Keay Nakae | Chardan Capital Markets |
Mani Foroohar | SVB Leerink |
Ladies and gentlemen, welcome to the Arrowhead Pharmaceuticals conference call. [Operator Instructions]. I will now hand the conference call over to Vince Anzalone, Vice President of Investor Relations for Arrowhead. Please go ahead, sir.
Thanks, Aldan.